INTERNATIONAL PATENT: CELLERON THERAPEUTICS LIMITED FILES APPLICATION FOR "COMBINATION OF CXD101 AND AN IL-15 SUPERAGONIST TO TREAT PROLIFERATIVE DISEASES SUCH AS CANCER"

GENEVA, April 14 -- CELLERON THERAPEUTICS LIMITED (Magdalen CentreOxford Science ParkOxford, Oxfordshire OX4 4GA) filed a patent application (PCT/GB2024/052525) for "COMBINATION OF CXD101 AND AN IL-15 SUPERAGONIST TO TREAT PROLIFERATIVE DISEASES SUCH AS CANCER" on Oct 02, 2024. With publication no. WO/2025/074090, the details related to the patent application was published on Apr 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LA THANGUE, Nicholas (c/o Celleron Therapeutics LimitedMagdalen CentreOxford Science ParkOxford, Oxfordshire OX4 4GA), BARCZAK, Wojciech (c/o Celleron Therapeutics...